Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Learning Health Systems
|
July 19, 2021
Seven practices for pursuing equity through learning health systems: Notes from the field
Allison Parsons, Ndidi I Unaka, Constance Stewart, et al.
Health & Social Care in the Community
|
February 9, 2021
Cultivating social relationships and disrupting social isolation in low-income, high-disparity neighbourhoods in Ohio, USA
Allison A Parsons, Dawna Leggett, Daniela Vollmer, et al.
Journal of the American Medical Directors Association
|
December 8, 2020
Online Education and Cognitive Behavior Therapy Improve Dementia Caregivers' Mental Health: A Randomized Trial
Jane Fossey, Georgina Charlesworth, Jo-Ann Fowler, et al.
JPGN Reports
|
June 16, 2022
Health-Related Social Needs Facing Youth with NonAlcoholic Fatty Liver Disease
Sarah Orkin, Toshifumi Yodoshi, Qin Sun, et al.
The American Journal of Cardiology
|
February 17, 2018
Corrigendum to 'Effects of RG7652, a Monoclonal Antibody Against PCSK9, on Low-Density Lipoprotein Cholesterol (LDL-C), LDL-C Subfractions, and Inflammatory Biomarkers in Patients at High Risk of or with Established Coronary Heart Disease (From the Phase 2 EQUATOR Study)' The American Journal of Cardiology 119 (2017) 1576-1583
Amos Baruch, Sofia Mosesova, John D Davis, et al.
The American Journal of Cardiology
|
March 28, 2017
Effects of RG7652, a Monoclonal Antibody Against PCSK9, on LDL-C, LDL-C Subfractions, and Inflammatory Biomarkers in Patients at High Risk of or With Established Coronary Heart Disease (from the Phase 2 EQUATOR Study)
Amos Baruch, Sofia Mosesova, John D Davis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 8, 2016
Phase I Study of the Anti-CD22 Antibody-Drug Conjugate Pinatuzumab Vedotin with/without Rituximab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Ranjana H Advani, Daniel Lebovic, Andy Chen, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
October 26, 2019
Community Socioeconomic Deprivation and Nonalcoholic Fatty Liver Disease Severity
Sarah Orkin, Cole Brokamp, Toshifumi Yodoshi, et al.
The Lancet. Oncology
|
May 1, 2015
Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study
Maria Corinna A Palanca-Wessels, Myron Czuczman, Gilles Salles, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 22, 2019
Phase Ia Study of Anti-NaPi2b Antibody-Drug Conjugate Lifastuzumab Vedotin DNIB0600A in Patients with Non-Small Cell Lung Cancer and Platinum-Resistant Ovarian Cancer
David E Gerber, Jeffrey R Infante, Michael S Gordon, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Learning Health Systems
|
July 19, 2021
Seven practices for pursuing equity through learning health systems: Notes from the field
Allison Parsons, Ndidi I Unaka, Constance Stewart, et al.
Health & Social Care in the Community
|
February 9, 2021
Cultivating social relationships and disrupting social isolation in low-income, high-disparity neighbourhoods in Ohio, USA
Allison A Parsons, Dawna Leggett, Daniela Vollmer, et al.
Journal of the American Medical Directors Association
|
December 8, 2020
Online Education and Cognitive Behavior Therapy Improve Dementia Caregivers' Mental Health: A Randomized Trial
Jane Fossey, Georgina Charlesworth, Jo-Ann Fowler, et al.
JPGN Reports
|
June 16, 2022
Health-Related Social Needs Facing Youth with NonAlcoholic Fatty Liver Disease
Sarah Orkin, Toshifumi Yodoshi, Qin Sun, et al.
The American Journal of Cardiology
|
February 17, 2018
Corrigendum to 'Effects of RG7652, a Monoclonal Antibody Against PCSK9, on Low-Density Lipoprotein Cholesterol (LDL-C), LDL-C Subfractions, and Inflammatory Biomarkers in Patients at High Risk of or with Established Coronary Heart Disease (From the Phase 2 EQUATOR Study)' The American Journal of Cardiology 119 (2017) 1576-1583
Amos Baruch, Sofia Mosesova, John D Davis, et al.
The American Journal of Cardiology
|
March 28, 2017
Effects of RG7652, a Monoclonal Antibody Against PCSK9, on LDL-C, LDL-C Subfractions, and Inflammatory Biomarkers in Patients at High Risk of or With Established Coronary Heart Disease (from the Phase 2 EQUATOR Study)
Amos Baruch, Sofia Mosesova, John D Davis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 8, 2016
Phase I Study of the Anti-CD22 Antibody-Drug Conjugate Pinatuzumab Vedotin with/without Rituximab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Ranjana H Advani, Daniel Lebovic, Andy Chen, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
October 26, 2019
Community Socioeconomic Deprivation and Nonalcoholic Fatty Liver Disease Severity
Sarah Orkin, Cole Brokamp, Toshifumi Yodoshi, et al.
The Lancet. Oncology
|
May 1, 2015
Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study
Maria Corinna A Palanca-Wessels, Myron Czuczman, Gilles Salles, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 22, 2019
Phase Ia Study of Anti-NaPi2b Antibody-Drug Conjugate Lifastuzumab Vedotin DNIB0600A in Patients with Non-Small Cell Lung Cancer and Platinum-Resistant Ovarian Cancer
David E Gerber, Jeffrey R Infante, Michael S Gordon, et al.
Page
of 3